| Application no. and date | 01931522.5 (espacenet) (Federated) (European Patent Register), 20010314 | | Patent/reg. no. and date | DK/EP 1265633, 20121212 | | Publication date | 20021218 | | Priority no. and date | DE 10012370, 20000314 | | EP pub. no. and date |
EP 1265633 20021218 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
CH-4056 Basel, CH | | Applicant ref. no. | 145794 | | Inventor | BRÖKER, Michael, Pappelweg 30
35041 Marburg, DE | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/116 (2006.01) , A61K 39/295 (2006.01) , A61K 39/39 (2006.01) , A61P 31/00 (2006.01) , A61P 37/04 (2006.01) | | Title | Vaccineadjuvans | | Int. application no. | EP2001002866 | | Int. publication no. | WO2001068129 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
